The expression and function of RASAL2 in renal cell carcinoma angiogenesis

Cell Death & Disease
Ke HuiKaijie Wu

Abstract

Patients with renal cell carcinoma (RCC) often develop resistance to antivascular drugs and eventually succumb to disease. However, the underlying molecular mechanism remains poorly understood. In this study, we demonstrated that RASAL2, a RAS GTPase-activating protein, played a tumor-suppressive role in RCC by targeting tumor angiogenesis. Firstly, we showed that RASAL2 was frequently epigenetically silenced in RCC, and its loss was negatively correlated with overall survival of RCC patients. Furthermore, we discovered that RASAL2 could inhibit RCC angiogenesis in vitro and in vivo. Mechanistically, we identified that RASAL2 could activate GSK3β by reducing Ser9 phosphorylation and subsequently decrease the expression of c-FOS and vascular endothelial growth factor A (VEGFA). Interruption of the p-GSK3β/c-FOS pathway with the specific inhibitor or small interfering RNA could reverse the expression of VEGFA, which may provide a new insight to prevent RCC from resistance to antivascular therapy.

References

Dec 17, 2004·Pharmacological Reviews·Ann HoebenErnst A De Bruijn
Mar 10, 2009·Lancet·Brian I RiniBernard Escudier
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Daxing XieJer-Tsong Hsieh
Jun 19, 2012·Seminars in Cancer Biology·Chuan Shen, William G Kaelin
Jun 26, 2013·Nature Genetics·Yusuke SatoSeishi Ogawa
Sep 14, 2013·Cancer Cell·Sara Koenig McLaughlinKaren Cichowski
Apr 26, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Barbara StefanskaMoshe Szyf
May 13, 2014·Advances in Biological Regulation·Ophélia Maertens, Karen Cichowski
Aug 26, 2014·Current Signal Transduction Therapy·Anna KornakiewiczAnna M Czarnecka
Nov 11, 2014·The Journal of Clinical Investigation·Min FengQiang Yu
Dec 3, 2014·Biochemical and Biophysical Research Communications·Ning Li, Suyun Li
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 17, 2017·Urologic Oncology·Peter J SiskaScott M Haake
May 4, 2017·The Journal of Experimental Medicine·Ye SunLois E H Smith
Sep 30, 2017·CA: a Cancer Journal for Clinicians·Pedro C Barata, Brian I Rini

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE40435
GSE16449
GSE11151

Methods Mentioned

BETA
PCR
Co-IP
xenograft
xenografts
transfection
ELISA

Software Mentioned

GraphPad
GraphPad Prism

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.